Skip to main content
SpringerLink
Log in

Speicheldrüsenmalignome

  • Chapter
Kompendium Internistische Onkologie

  • 118 Accesses

Zusammenfassung

Häufigkeit: Speicheldrüsenkarzinome haben einen Anteil von etwa 7% an allen malignen epithelialen Kopf-Hals-Tumoren.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Literatur

  • Airoldi M, Bertetto O, Gabriele P et al (1998) Cisplatin (DDP) + Vinorelbine (VNB) vs. VNB alone in recurrent salivary gland malignancies (RSGM): A randomized trial. Proc AM Soc Clin Oncol 383a:1475

    Google Scholar 

  • Alberts DS et al (1981) Adriamycin/cis-platinum/cyclophosphamide combination chemotherapy for advanced carcinoma of the parotis gland. Cancer 47:645–648

    Article  PubMed  CAS  Google Scholar 

  • Franchi A, Gallo O, Bocciolini C et al (1999) Reduced E-cadherin expression correlates with unfavorable prognoses in adenoidcystic carcinoma of salivary glands of the oral cavity. Am J Clin Pathol 111:43–50

    PubMed  CAS  Google Scholar 

  • Gallo O, Franchi A, Bianchi S et al (1995) p53 oncoprotein expression in parotid gland carcinoma is associated with clinical outcome. Cancer 75:2037–2044

    Article  PubMed  CAS  Google Scholar 

  • Sessions R, Harrison L, Forastiere K (1997) Tumors of the salivary gland. In: DeVita (ed) Principles and Practice 2. Cancer Medicine

    Google Scholar 

  • Terhaard CHJ, Lubsen H, van der Tweel I et al (2004) Salivary gland carcinoma: independent prognostic factors for locoregional control and distant metastases: results of the Dutch head and neck oncology cooperative group. Head Neck Surg 26: 681–692

    Article  Google Scholar 

  • Venook AP, Zeng A, Meiers FJ et al (1987) Cisplatin, doxorubicin and 5-fluorouracil chemotherapy for parotid gland malignancies–A pilot study of the Northern California Oncology Group. J Clin Oncol 5:951–955

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. A. M. Marres
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. H. A. M. Kaanders
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. A. Werner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. G. Wendt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I. Bruaset
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. A. M. Pop
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. H. M. De Mulder
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H. -J. Schmoll
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Schwerpunkt Hämatologie/Onkologie, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Straße 40, 06120, Halle/Saale

    Hans-Joachim Schmoll (Direktor der Klinik und Poliklinik für Innere Medizin IV) (Direktor der Klinik und Poliklinik für Innere Medizin IV)

  2. Onkologie-Hämatologie-Gastroenterologie-Hepatologie-Infektiologie, Klinikum der Friedrich-Schiller-Universität Jena, Erlanger Allee 101, 07740, Jena

    Klaus Höffken (Direktor der Klinik und Poliklinik für Innere Medizin II) (Direktor der Klinik und Poliklinik für Innere Medizin II)

  3. Schwerpunkt Onkologie und Hämatologie, Universitätsmedizin Berlin, Charité-Campus Mitte Schumannstraße 20/21, 10117, Berlin

    Kurt Possinger (Direktor der Medizinischen Klinik II) (Direktor der Medizinischen Klinik II)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Marres, H.A.M. et al. (2006). Speicheldrüsenmalignome. In: Schmoll, HJ., Höffken, K., Possinger, K. (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31303-6_198

Download citation

  • DOI: https://doi.org/10.1007/3-540-31303-6_198

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20657-6

  • Online ISBN: 978-3-540-31303-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation